Featured Coverage

• Predictors of Risk in Hypertensive PatientsAssessment of blood pressure is a fundamental measure of cardiovascular risk, but a couple of small studies found further information could be derived from other cardiac measures.
• Do Statins Have a Role in Heart Failure?Statins are among the safest and most effective drugs in the cardiovascular disease armamentarium, but up to now there has been no evidence that they will also have benefits in HF patients.
• Adjuvant Therapy in Acute Coronary Syndromes: Optimizing CareThe studies reviewed here capture the ongoing quest for more effective and efficacious drugs, as well as the need to determine optimal durations of therapy in acute coronary syndromes.
• Heparins in PCI: LMWH vs UFH -- Do We Have All the Answers?The STEEPLE results coupled with the results of a large meta-analysis further document the safety of LMWH vs UFH in patients undergoing elective or urgent PCI.
• The FINESSE and CARESS in AMI Trials: Is Facilitated PCI Ready for Prime Time?Do the results of these trials provide a clear indication for the routine use of facilitated PCI in STEMI patients?

Conference News

• Pregnancy in Congenital Heart Disease: New Predictors of Complications
  Heartwire, October 16, 2007
• CME/CE Time for PAD to Come Out of the Shadows, Say GetABI Researchers
  Medscape Medical News, September 7, 2007
• CME ADVANCE: Perindopril/Indapamide for All Type 2 Diabetes Patients?
  Medscape Medical News, September 5, 2007
• ACUITY: One-Year Results, Some Interesting Observations
  Heartwire, September 11, 2007
• STEEPLE at One Year: No Mortality Differences Between Enoxaparin and Unfractionated Heparin
  Heartwire, September 10, 2007
• Sudden Cardiac Death More Common Than Thought Among the Young
  Heartwire, September 10, 2007
• OPTIMIST: Outcomes Bleak Following PCI for Stent Thrombosis
  Heartwire, September 5, 2007
• Hope At Last? Bosentan for Inoperable PAH
  Heartwire, September 5, 2007
• MERLIN TIMI-36: Antianginal Agent Ranolazine Shown to Be Antiarrhythmic
  Heartwire, September 5, 2007
• Statin Benefits in Heart Failure Include Protection Against Sudden Death in Pilot Trial
  Heartwire, September 5, 2007
• New Swedish Registry Results Show no Overall Increased Deaths With DES Out to 4 Years
  Heartwire, September 4, 2007
• SEARCH-MI: Appropriate ICD Therapy in Real-World Registry of Post-MI Patients
  Heartwire, September 4, 2007
• EUROASPIRE Uninspiring: Obesity and Smoking Wipe Out Any Gains
  Heartwire, September 4, 2007
• Symptom Benefits, But No Life Savings With Noninvasive Ventilation for Acute Cardiogenic Pulmonary Edema
  Heartwire, September 4, 2007
• Another RAS Inhibitor for Heart Failure? Aliskiren Okay on Top of Standard Meds in Safety Study
  Heartwire, September 4, 2007
• ADVANCE Reinforces Message to Aggressively Treat Blood Pressure in Diabetics
  Heartwire, September 4, 2007
• PRAGUE-8: Pretreatment With Clopidogrel Before Angiography Not Justified in Stable CAD Patients
  Heartwire, September 4, 2007
• OASIS-5 Substudy: Women Fare Worse With Invasive Strategy
  Heartwire, September 4, 2007
• FINESSE: Abciximab-only- and Lytic/Abciximab-Facilitated PCI No Better Than Primary PCI
  Heartwire, September 4, 2007
• CARESS: PCI After Lysis Beneficial?
  Heartwire, September 4, 2007
• Triple Antiplatelet Therapy Found Excessive at Interventions for Old, Total Peripheral Occlusions
  Heartwire, September 4, 2007
• Irish Smoking Ban Reduced the Rate of Admissions for Acute Coronary Syndromes
  Heartwire, September 4, 2007
• DES Fall From GRACE in STEMI: Patients Face More Than Fourfold Higher Risk of Death Than Bare-Metal-Stent-Treated Patients
  Heartwire, September 4, 2007
• WENBIT: Another Negative Trial With B Vitamins
  Heartwire, September 4, 2007
• Not Ready for Prime Time: Echo for Identifying Bi-V Pacing Responders in Heart Failure
  Heartwire, September 4, 2007